MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    The key is “any movement”: results from a Cochrane systematic review and network meta-analysis on physical interventions for Parkinson´s disease

    M. Ernst, AK. Folkerts, M. Roheger, D. Chakraverty, F. Krohm, J. Caro-Valenzuela, R. Gollan, E. Lieker, A. Adams, C. Eggers, I. Monsef, A. Dresen, N. Skoetz, E. Kalbe (Cologne, Germany)

    Objective: To compare the efficacy and safety of physical interventions for people with Parkinson's disease (PD). Background: Physical interventions are effective in managing PD, but…
  • 2022 International Congress

    Bis(monoacylglycerol) phosphate levels are elevated at baseline in carriers of pathogenic variants in LRRK2 and GBA1 and do not predict progression of PD in PPMI cohorts

    K. Merchant, T. Simuni, J. Fedler, M. Brumm, C. Caspell, E. Tangstrandt, F. Hsieh, K. Nudelman, T. Foroud, C. Coffey, A. Siderowf, C. Tanner, K. Marek, P. Investigators (Chicago, USA)

    Objective: To assess: (a) effects of LRRK2 and GBA1 pathogenic variants on baseline urinary bis(monoacylglycerol) phosphate (BMP) levels in those with and without Parkinson’s disease…
  • 2022 International Congress

    Factors associated with progression of Parkinson’s disease and deterioration in quality of life: Results of J-FIRST, a 1-year observational study

    K. Kashihara, S. Chiu, Y. Tsuboi, N. Hattori, M. Nomoto, H. Watanabe, T. Maeda, H. Saiki, Y. Shimo, T. Yamaguchi (Okayama, Japan)

    Objective: To investigate whether individual non-motor symptoms (NMSs) are associated with overall NMS or quality of life (QOL) in Parkinson's disease (PD). Background: Worsening motor…
  • 2022 International Congress

    Catatonic Syndrome in Covid-19 Infection: Medication Treatment or Hyperbaric Oxygen Therapy.

    D. Labunskiy, S. Kiryukhina, V. Podsevatkin (Saransk, Russian Federation)

    Objective: Catatonic syndrome, or catatonia (from other Greek κατατείνω - “stretch, strain”), is a psychopathological syndrome (a group of symptoms), the main clinical manifestation of…
  • 2022 International Congress

    Prevalence and distribution of disease-associated alpha-synuclein in a homeless population

    N. Visanji, K. Danics, G. Kovacs (Toronto, Canada)

    Objective: To study the prevalence and distribution of pathological alpha-synuclein deposition, throughout the central and peripheral nervous systems, in a homeless population. Background: The homeless…
  • 2022 International Congress

    Vodobatinib, a potent, orally bioavailable brain-penetrating inhibitor of c-Abl as a potential neuroprotective agent for the treatment of Parkinson’s Disease

    R. Walsh, S. Piccoli, O. Hurko, N. Damle, V. Ramanathan, S. Yao, D. Love, S. Mandhane, R. Talluri (Princeton, USA)

    Objective: To compare and contrast nilotinib and vodobatinib regarding efficacy, brain penetration, and safety. Background: Preclinical evidence suggests that c-Abl is critical for pathogenesis of…
  • 2022 International Congress

    Atypical parkinsonism presenting in late 60s in an individual with GCH1 mutation

    P. Barbosa, MG. Ghilardi, AC. Campos, F. Curado, P. Bauer, E. Fonoff (Sao Paulo, Brazil)

    Objective: To report a case of possible comorbid tau and Lewy pathology in an individual with a GCH1 mutation. Background: A 69-year-old man developed atypical parkinsonism…
  • 2022 International Congress

    Occlusal Stabilization Appliance on treatment of cervical dystonia

    M. Salari, M. Etemadifar (Tehran, Islamic Republic of Iran)

    Objective: To evaluate the effect of occlusal stabilization appliance on cervical dystonia. Background: Cervical dystonia is a contraction of the neck muscles that causes movement…
  • 2022 International Congress

    Is motor symptoms asymmetry a possible predictor of short-term motor outcome of bilateral STN-DBS in Parkinson’s disease?

    F. Cavallieri, F. Bove, A. Castrioto, S. Meoni, E. Schmitt, A. Bichon, A. Kistner, P. Pélissier, E. Lhommée, E. Chevrier, S. Chabardès, E. Seigneuret, V. Fraix, E. Moro (Reggio Emilia, Italy)

    Objective: To evaluate if the body side of motor symptoms onset may predict the short-term motor outcome of bilateral subthalamic nucleus deep brain stimulation (STN-DBS)…
  • 2022 International Congress

    Lower-limb dystonia as an explanation for freezing of gait responsive to cueing in Parkinson’s Disease

    M. Dias, M. Soares (Lisbon, Portugal)

    Objective: We aimed to search the literature for a potential association between freezing of gait (FOG) with cueing and dystonia with sensory tricks in Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley